Data from the National Health and Nutrition Examination Survey III was used to determine whether coffee has an effect on cardiovascular and all-cause mortality.
The FDA has granted clearance for its HealthPatch MD biosensor for 24-hour patient monitoring in their homes.
Amgen announced that it has submitted a Biologics License Application (BLA) to the FDA for evolocumab for the treatment of high cholesterol.
A staple in the diet of many college students could increase the risk of metabolic syndrome in women, independent of major dietary patterns.
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the reduction in the risk of recurrent DVT and PE following initial therapy.
Mylan announced its launch of Potassium Chloride Extended-Release Tablets, the generic version of Upsher-Smith's Klor-Con.
The benefits of long-term aspirin therapy for secondary stroke prevention may outweigh the risks typically associated with aspirin.
To reduce thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease (PAD).